# Phase 24 Review - Multi-Case Report Quality Loop

Date: 2026-05-15
Cycle: 28
Scope: T104-T109

## Verdict

Stop-Ship: No

Severity counts:

| Severity | Count | Status |
|---|---:|---|
| P0 | 0 | none |
| P1 | 0 | none |
| P2 | 3 | accepted carry-forward caveats |

Phase 24 may advance to Phase 25 because the dashboard identifies 3 controlled
internal demo-quality packs, including positive and limitation examples, and no
unresolved P0/P1 report-validity findings.

## Evidence Reviewed

- `docs/REPORT_QUALITY_SCORECARD.md`
- `docs/OPEN_SOURCE_RULE_COVERAGE_MATRIX.md`
- `docs/OPEN_SOURCE_AUDIT_QUALITY_DASHBOARD.md`
- `docs/PHASE24_REGRESSION_DECISIONS.md`
- `docs/INTERNAL_DEMO_PACK_OPEN_SOURCE_AUDITS.md`
- `docs/audit/PHASE23_ERROR_REGISTER.md`
- `trader_risk_audit/reporting/claim_guard.py`
- `tests/unit/reporting/test_claim_guard.py`

## Validation

- `.venv/bin/python -m pytest tests -q --tb=short` -> 258 passed
- `.venv/bin/python -m ruff check trader_risk_audit tests` -> passed
- `.venv/bin/python -m ruff format --check trader_risk_audit tests` -> passed
- `case-bank validate` -> passed for `open_source_sec_form4_001`,
  `public_sample_001`, `risk_audit_case_001`, and
  `synthetic_limit_leverage_001`

## Findings

No new findings.

Carry-forward accepted P2 caveats:

| ID | Summary | Required handling |
|---|---|---|
| PH23-P2-001 | SEC Form 4 is disclosure data, not a customer ledger. | Keep as internal reference only. |
| PH23-P2-002 | Public sample P&L wording requires reviewed-copy caveat. | Keep caveat visible before demo use. |
| PH23-P2-003 | Synthetic positive findings are not market/customer evidence. | Keep synthetic provenance visible. |

## Phase 25 Entry Conditions

Phase 25 may begin with T110. It must not commit private raw rows or add hosted
scope. The next phase should build private intake/redaction and report-review
checklists before any operator-approved private run notes are recorded.
